Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated with a better prognosis than idiopathic usual interstitial pneumonia (UIP) because only a limited number of patients with SSc progress to end stage fibrosis. Mechanisms driving the fibrotic evolution of ILD are still poorly understood, but, recently, on the basis of animal models, a pathogenetic role has been ascribed to an imbalance in the local Th1/Th2 response, with an expansion of the Th2 profile
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now t...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Various cytokines are known to participate in the pathogenesis of interstitial pneumonia follewed by...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wi...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wit...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
OBJECTIVE: The pathophysiology of the lung fibrotic process in systemic sclerosis (SSc) is not fully...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Introduction: So far no clinical or experimental evidences clearly explain how and which systemic sc...
This study was designed to investigate the levels of IL-2 and its soluble receptor (sIL-2R) in bronc...
INTRODUCTION: So far no clinical or experimental evidences clearly explain how and which systemic s...
In systemic sclerosis (SSc), interstitial lung disease (ILD) is common (>80%) and worsens the pro...
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now t...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Various cytokines are known to participate in the pathogenesis of interstitial pneumonia follewed by...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wi...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wit...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
OBJECTIVE: The pathophysiology of the lung fibrotic process in systemic sclerosis (SSc) is not fully...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% ...
Introduction: So far no clinical or experimental evidences clearly explain how and which systemic sc...
This study was designed to investigate the levels of IL-2 and its soluble receptor (sIL-2R) in bronc...
INTRODUCTION: So far no clinical or experimental evidences clearly explain how and which systemic s...
In systemic sclerosis (SSc), interstitial lung disease (ILD) is common (>80%) and worsens the pro...
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now t...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Various cytokines are known to participate in the pathogenesis of interstitial pneumonia follewed by...